Tekla Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.05M | Hold |
1,551,082
| – | – | 0.08% | 112 |
|
|
2023
Q1 | $1.1M | Hold |
1,551,082
| – | – | 0.04% | 137 |
|
|
2022
Q4 | $1.16M | Hold |
1,551,082
| – | – | 0.04% | 132 |
|
|
2022
Q3 | $1.34M | Hold |
1,551,082
| – | – | 0.05% | 124 |
|
|
2022
Q2 | $1.74M | Hold |
1,551,082
| – | – | 0.07% | 117 |
|
|
2022
Q1 | $1.74M | Hold |
1,551,082
| – | – | 0.06% | 130 |
|
|
2021
Q4 | $2.48M | Hold |
1,551,082
| – | – | 0.08% | 123 |
|
|
2021
Q3 | $3.75M | Buy |
1,551,082
+506,292
| +48% | +$1.23M | 0.12% | 115 |
|
|
2021
Q2 | $3.31M | Buy |
1,044,790
+47,500
| +5% | +$151K | 0.11% | 137 |
|
|
2021
Q1 | $3.36M | Buy |
+997,290
| New | +$3.36M | 0.12% | 139 |
|